Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
AssigneesBoehringer Ingelheim Animal Health USA Inc., Iowa State University Research Foundation, Inc.
InventorsArun IYER, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
Claims13
1-141. (canceled)
A method of producing an immune response against porcine circovirus type 3 (PCV3) in a pregnant sow or pregnant gilt, wherein said method comprises administering a recombinant PCV3 ORF2 protein to the pregnant sow or pregnant gilt.
A method of producing an immune response against porcine circovirus type 3 (PCV3) in a pregnant sow or pregnant gilt, wherein said method comprises administering a composition comprising a recombinant PCV3 ORF2 protein to the pregnant sow or pregnant gilt.
Dependencies are inferred from the claim text.